Newcastle Surgery
Cefn Glas, Bridgend, CF31 4XX
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 16 | 18 | 88.9% | |
| HF 4 | 2011 | 19 | 22 | 86.4% | |
| HF 4 | 2012 | 40 | 60 | 66.7% | |
| HF 4 | 2013 | 39 | 54 | 72.2% | |
| HF004W | 2014 | 25 | 31 | 80.6% | |
| HF004 | 2015 | 24 | 28 | 85.7% |
